Medical

Penn State researchers develop a glucose sensor that needs no needles

Penn State researchers develop a glucose sensor that needs no needles

One of the most common factors that prevents people with diabetes from routinely monitoring their blood sugar levels is that most modern machines require needles and small amounts of blood. However, researchers at Pennsylvania State University have developed a new glucose monitoring system that needs no needles to obtain accurate readings. The new wearable device promises a less intrusive glucose monitoring system that could become the normal way people suffering from diabetes monitor glucose.

Continue Reading

Johnson & Johnson COVID-19 vaccine booster gets FDA panel recommendation

Johnson & Johnson COVID-19 vaccine booster gets FDA panel recommendation

Only a day after recommending an emergency use authorization for Moderna's booster vaccine dose, the FDA panel of advisers is back with a similar recommendation for Johnson & Johnson's Janssen COVID-19 vaccine. The committee unanimously voted in favor of granting J&J an emergency use authorization, though the terms under which the booster would be offered differs from the EUA granted to Pfizer.

Continue Reading

Blood pressure and fluid retention drugs recalled over cancer concerns

Blood pressure and fluid retention drugs recalled over cancer concerns

The FDA has published a new recall advisory from Lupin Pharmaceuticals over two different drugs: Hydrochlorothiazide and Irbesartan. The company, which stopped marketing these particular drugs in January, says it is recalling the batches due to potentially higher than acceptable levels of an impurity called N-nitrosoirbesartan.

Continue Reading

Severe virus infections in teens may fuel MS development later in life

Severe virus infections in teens may fuel MS development later in life

A new study explores the link between certain viral infections during one's youth and the onset of multiple sclerosis (MS) later in life. The autoimmune disease cannot be cured and though studies have shed light on how the condition may come about, there are still many mysteries that need to be unraveled.

Continue Reading

FDA panel recommends Moderna booster shot EUA for certain people

FDA panel recommends Moderna booster shot EUA for certain people

A Food and Drug Administration advisory panel has unanimously recommended granting emergency use authorization for a third Moderna shot, though only some people would be eligible for the booster shot. The recommendation follows Moderna's second-quarter financial details shared in August, which included information on the COVID-19 vaccine's efficacy six months after the second dose, as well as the booster for its booster shots to help protect against SARS-CoV-2 variants.

Continue Reading

NIH says common water pill shows promise as repurposed Alzheimer’s drug

NIH says common water pill shows promise as repurposed Alzheimer’s drug

There are many existing drugs that have, in some cases, been on the market for decades with authorization for specific conditions. The National Institutes of Health recently funded research into an exploration of these existing drugs for one that can potentially be repurposed as an Alzheimer's treatment -- and, the NIH has announced, a possible candidate has been discovered. The potential Alzheimer's treatment is a common water pill (diuretic) that is already FDA approved.

Continue Reading

Experimental Alzheimer’s drug found to trigger fat burning without diet

Experimental Alzheimer’s drug found to trigger fat burning without diet

An enzyme inhibitor developed by Pfizer and tested as a potential Alzheimer's treatment is the subject of a new study, but it has nothing to do with memory. Rather, the researchers found that inhibiting an enzyme called PDE9 caused overweight mice to burn a considerable amount of fat without changes to their diet and activity level...though there was one very big catch.

Continue Reading

WHO recommends first malaria vaccine for kids as young as 5 months

WHO recommends first malaria vaccine for kids as young as 5 months

The World Health Organization has recommended the protein-based recombinant malaria vaccine RTS,S for use with kids who live in places with moderate and high transmission risk. The organization announced its recommendation today, stating that there should be "widespread use" of this vaccine with children following a smaller pilot program in select countries.

Continue Reading

Cannabis ‘mother’ compound CBGA beats CBD at treating seizures

Cannabis ‘mother’ compound CBGA beats CBD at treating seizures

As the public perception of cannabis ('marijuana') evolves and laws in many states follow, researchers are once again studying the drug for its potential medicinal benefits. Among the possible conditions alleviated by cannabis compounds is epilepsy, the subject of a new study from the University of Sydney's Lambert Initiative for Cannabinoid Therapeutics.

Continue Reading

Study finds common cancer drug reverses Alzheimer’s symptoms

Study finds common cancer drug reverses Alzheimer’s symptoms

A new study reports that a common cancer drug can be used to restore cognition and memory in mice with Alzheimer's symptoms. The research was recently published by scientists at the University of British Columbia. Among other things, the mice that were treated with this drug performed better in tests designed to evaluate memory and the ability to learn.

Continue Reading

Scientists accidentally develop powerful rheumatoid arthritis vaccine

Scientists accidentally develop powerful rheumatoid arthritis vaccine

In an attempt to discover whether a particular protein is a trigger for rheumatoid arthritis, scientists with the University of Toledo accidentally discovered a vaccine against the painful autoimmune disease. The protein-based vaccine was found to generate a fast, strong, and long-lasting immune system response that offers protection from the disease.

Continue Reading

Merck says its COVID-19 pill drastically reduced deaths during trial

Merck says its COVID-19 pill drastically reduced deaths during trial

Pharmaceutical company Merck has announced that its molnupiravir pill-based COVID-19 treatment "significantly" reduced the rates of hospitalization and death among patients during its Phase 3 MOVe-OUT trial. The benefits were observed among participants who had mild to moderate COVID-19, but who weren't hospitalized at the time they started taking the oral treatment.

Continue Reading

1 2 3 4 Next